Sphingosine kinase 1 as an anticancer therapeutic target
Ying Gao,1,* Fei Gao,2,* Kan Chen,3,* Mei-li Tian,1 Dong-li Zhao1 1Department of Radiotherapy Oncology, First Affiliated Hospital of Xi’an Jiaotong University, 2Department of Neurology, First Affiliated Hospital of Xi’an Medical University, Xi’an, 3School of Life Scienc...
Saved in:
Main Authors: | Gao Y (Author), Gao F (Author), Chen K (Author), Tian ML (Author), Zhao DL (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2015-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Determining the Anticancer Activity of Sphingosine Kinase Inhibitors Containing Heteroatoms in Their Tail Structure
by: Jitendra Shrestha, et al.
Published: (2022) -
Sphingosine Kinases and Sphingosine 1-Phosphate Receptors: Signaling and Actions in the Cardiovascular System
by: Alessandro Cannavo, et al.
Published: (2017) -
Identifying novel sphingosine kinase 1 inhibitors as therapeutics against breast cancer
by: Faez Iqbal Khan, et al.
Published: (2020) -
Transcriptome-Wide Effects of Sphingosine Kinases Knockdown in Metastatic Prostate and Breast Cancer Cells: Implications for Therapeutic Targeting
by: Heba Alshaker, et al.
Published: (2019) -
Commentary: Sphingosine-1-phosphate inhibitors are potential therapeutic targets for pulmonary arterial hypertension
by: Naga P Bhavanam, et al.
Published: (2015)